TL;DR
This paper introduces a wearable laser Doppler flowmetry (LDF) device for non-invasively assessing microcirculation in the feet of individuals with Type 2 Diabetes Mellitus (T2DM). By analyzing blood flow oscillations with wavelet analysis and sample entropy, the study reveals impaired microvascular function in diabetic patients, particularly in the plantar regions, suggesting the device's potential for early detection and intervention of diabetic foot complications.
What Problem Does This Paper Address?
Diabetic foot (DF) is a severe complication of Type 2 Diabetes Mellitus (T2DM) that can lead to ulceration, infection, and amputation. A key factor in DF development is microvascular dysfunction, where the small blood vessels in the feet become impaired. Current methods for assessing foot microcirculation are often limited to laboratory settings, lacking portability and quantitative capabilities. This makes it challenging to effectively monitor patients and identify those at high risk for DF. The paper aims to address this by developing and validating a wearable LDF system for non-invasive, quantitative assessment of foot microcirculation, focusing on methodological considerations and clinical implications for T2DM patients.
Methods
The study employed a wearable laser Doppler flowmetry (LDF) device to measure blood flow (BF) in four distinct regions of the foot: the first metatarsal head (M1), fifth metatarsal head (M5), heel, and dorsal foot. The collected LDF signals were then analyzed using two primary techniques:
- Wavelet Analysis: This method decomposes the BF signal into different frequency components, each associated with specific physiological control mechanisms. The paper identifies five such components: endothelial, neurogenic, myogenic, respiratory, and heart. This allows for a nuanced understanding of how different regulatory systems contribute to blood flow.
- Sample Entropy (SE): SE was used to quantify the complexity and regularity of the time series of blood flow within each wavelet component. A lower SE value indicates less complexity and higher self-similarity, suggesting a more predictable or potentially impaired regulatory system.
The study compared these measures between 11 T2DM patients and 12 healthy individuals. Statistical analyses, including Shapiro-Wilk tests for normality, T-tests, and Wilcoxon rank-sum tests, were used to compare mean BF and SE values between groups and across different foot regions.
Datasets
The study utilized data collected from two groups of participants:
- 11 patients with Type 2 Diabetes Mellitus (T2DM).
- 12 healthy individuals.
The paper does not mention the use of any pre-existing datasets for training or evaluation, nor does it introduce a new benchmark dataset. All data was collected specifically for this study.
Key Insights and Ideas
- Wearable LDF for Diabetic Foot Assessment: The study successfully demonstrates the feasibility of using a wearable LDF device for non-invasive assessment of foot microcirculation in T2DM patients, overcoming the limitations of traditional laboratory-based systems.
- Microcirculation Impairment in T2DM: Diabetic patients exhibited significantly reduced mean blood flow (BF) in the neurogenic and heart components at the M1 region, and in the neurogenic component at the M5 region, compared to healthy controls. This highlights specific areas of vascular dysfunction.
- Complexity Reduction in Diabetic Microcirculation: Diabetic patients showed significantly lower sample entropy (SE) in several components across different foot regions, particularly in the neurogenic and myogenic components at M1, the endothelial component at M5, and the myogenic component at the dorsal foot. This suggests a loss of complexity and potentially impaired regulatory mechanisms in their microcirculation.
- Regional Differences in Diabetic Feet: The study identified distinct patterns of microcirculation impairment across different foot regions. While plantar areas (M1 and M5) showed reduced BF in certain components, the dorsal foot exhibited reduced SE in myogenic and heart components, suggesting a complex interplay of impaired regulation across the foot.
- Early Indicator of Neuropathy: The observed impairments in neurogenic components, even in patients without diagnosed peripheral neuropathy, suggest that LDF with wavelet analysis might detect microcirculation damage earlier than conventional methods.
Key Results
- Mean BF: Diabetic patients showed significantly lower mean BF in the neurogenic (p=0.044) and heart (p=0.001) components at the M1 region, and in the neurogenic component at the M5 region (p=0.025) compared to healthy adults.
- Sample Entropy (SE):
- At M1, diabetic patients had significantly lower SE in the neurogenic (p=0.049) and myogenic (p=0.032) components.
- At M5, diabetic patients had significantly lower SE in the endothelial component (p<0.001).
- At the dorsal foot, diabetic patients had significantly lower SE in the myogenic component (p=0.007).
- Within diabetic patients, SE in the myogenic component at the dorsal foot was lower than at the M5 (p=0.050) and heel (p=0.041) areas. Similarly, SE in the heart component at the dorsum was lower than at M5 (p=0.017) and heel (p=0.028).
Limitations and Future Work
The authors acknowledge several limitations:
- Sample Size: The study included a relatively small sample size (11 diabetic patients and 12 healthy adults), which may affect the reliability of the findings. Future studies should aim to include larger cohorts.
- Recording Duration: The 3-minute recording interval might be insufficient for robust analysis of low-frequency components, particularly those related to endothelial and neurogenic control. Extending the recording time in future research is recommended.
- Limited Assessment of Reactivity: The study focused on resting-state microcirculation. While microvascular reactivity is crucial for characterizing BF control mechanisms, tests like thermal or reactive hyperemia are time-consuming and may not be practical for frequent screening.
- Severity of Neuropathy: The study could not further evaluate the severity of neurogenic impairment. Future work could explore using LDF to quantify neurogenic impairment more precisely, potentially moving beyond traditional filament tests.
The authors suggest that future studies should:
- Utilize wearable LDF devices for walking assessments to compare different microvascular reactivity.
- Include larger sample sizes to improve the reliability of results.
- Explore the potential of this technology for early intervention and prevention of diabetic foot ulcers (DFUs).
Summary updated